Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fate of the Morbidly Obese Patient Who Is Denied Total Joint Arthroplasty
Joshua Shapiro, Arvind S. Narayanan, Patrick R. Taylor, et al.
The Journal of Arthroplasty (2020) Vol. 35, Iss. 6, pp. S124-S128
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Projected Prevalence of Obesity in Primary Total Hip Arthroplasty: How Big Will the Problem Get?
Christopher N. Carender, Natalie Glass, David E. DeMik, et al.
The Journal of Arthroplasty (2022) Vol. 37, Iss. 5, pp. 874-879
Closed Access | Times Cited: 35
Obesity, preoperative weight loss, and telemedicine before total joint arthroplasty: a review
Michael W. Seward, Antonia F. Chen
Arthroplasty (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 28
Frank Stinchfield Award: Does Bariatric Surgery Prior to Primary Total Hip Arthroplasty Really Improve Outcomes?
Sean P. Ryan, Cory G. Couch, Stephanie Q. Duong, et al.
The Journal of Arthroplasty (2022) Vol. 37, Iss. 7, pp. S386-S390
Closed Access | Times Cited: 28
Go Big or Go Home: Obesity and Total Joint Arthroplasty
Michael Blankstein, James A. Browne, Kevin A. Sonn, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 10, pp. 1928-1937
Closed Access | Times Cited: 17
Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry?
Matthew L. Magruder, David Jacofsky, Bryan D. Springer, et al.
The Journal of Arthroplasty (2024) Vol. 39, Iss. 2, pp. 277-282
Closed Access | Times Cited: 7
Obesity and Primary Total Hip Arthroplasty: The Absolute versus Relative Risk of Periprosthetic Joint Infection at 15 Years
Christopher N. Carender, Kristin M. Fruth, David G. Lewallen, et al.
The Journal of Arthroplasty (2024) Vol. 39, Iss. 9, pp. S436-S443.e1
Closed Access | Times Cited: 7
Preoperative Nonsurgical Weight Loss Interventions Before Total Hip and Knee Arthroplasty: A Systematic Review
Michael W. Seward, Logan Briggs, Paul Bain, et al.
The Journal of Arthroplasty (2021) Vol. 36, Iss. 11, pp. 3796-3806.e8
Closed Access | Times Cited: 40
Are Body Mass Index Cutoffs Creating Racial, Ethnic, and Gender Disparities in Eligibility for Primary Total Hip and Knee Arthroplasty?
Christopher N. Carender, David E. DeMik, Jacob M. Elkins, et al.
The Journal of Arthroplasty (2022) Vol. 37, Iss. 6, pp. 1009-1016
Closed Access | Times Cited: 22
Projected Prevalence of Obesity in Primary Total Knee Arthroplasty: How Big Will the Problem Get?
Christopher N. Carender, Natalie Glass, David E. DeMik, et al.
The Journal of Arthroplasty (2022) Vol. 37, Iss. 7, pp. 1289-1295
Closed Access | Times Cited: 22
Einfluss von Adipositas auf das mittelfristige Outcome in der primären Hüft- und Knieendoprothetik
Jörg Lützner, Oliver Melsheimer, Alexander Grimberg, et al.
Deleted Journal (2025)
Closed Access
Is There a Difference in PROMs Between Morbidly Obese Patients and Nonobese Patients Following Primary Total Knee Arthroplasty?
Sarag Abhari, Evan B. Rhea, Derek D. Arrington, et al.
Arthroplasty Today (2023) Vol. 22, pp. 101169-101169
Open Access | Times Cited: 11
The Impact of Glucagon-Like Peptide-1 Agonists on Hip and Knee Arthroplasty and Perioperative Considerations
David Jacofsky, Bryan D. Springer, Michael A. Mont, et al.
The Journal of Arthroplasty (2023) Vol. 39, Iss. 6, pp. 1455-1458
Closed Access | Times Cited: 11
Obesity and Primary Total Knee Arthroplasty: The Absolute versus Relative Risk of Periprosthetic Joint Infection at 15 Years
Christopher N. Carender, Kristin M. Fruth, David G. Lewallen, et al.
The Journal of Arthroplasty (2024)
Closed Access | Times Cited: 3
Perception of Risk: A Poll of American Association of Hip and Knee Surgeons Members
Adolph J. Yates, Lynne C. Jones, Charles L. Nelson, et al.
The Journal of Arthroplasty (2020) Vol. 36, Iss. 5, pp. 1471-1477
Closed Access | Times Cited: 23
Does Preoperative Weight Loss Within 6 Months or 1 Year Change the Risk of Adverse Outcomes in Total Knee Arthroplasty by Initial Body Mass Index Classification?
Albert J. Rechenmacher, William S. Yancy, Michael P. Bolognesi, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 12, pp. 2517-2522.e2
Closed Access | Times Cited: 7
Osteoarthritis and obesity; conservative management, multi-morbidity, surgery and the implications of restricted access to knee or hip replacement: a literature review
James Midgley
International Journal of Orthopaedic and Trauma Nursing (2020) Vol. 40, pp. 100840-100840
Closed Access | Times Cited: 20
Perception of Perioperative Risk for Arthroplasty Patients: A Poll of Australian Orthopedic Surgeons
Christopher J. Wall, Richard de Steiger, Jonathan Mulford, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 8, pp. 1418-1422
Closed Access | Times Cited: 6
Clinical Pathways of Patients Denied Total Knee Arthroplasty Due to an Institutional BMI Cutoff
Charlie D. Wilson, Kathleen F. Lundquist, Nathan H. Baruch, et al.
The Journal of Knee Surgery (2021) Vol. 35, Iss. 12, pp. 1364-1369
Open Access | Times Cited: 11
Glucagon-Like Peptide-1 Receptor Agonists Decrease Medical and Surgical Complications in Morbidly Obese Patients Undergoing Primary TKA
Billy I. Kim, Scott M. LaValva, Michael L. Parks, et al.
Journal of Bone and Joint Surgery (2024)
Closed Access | Times Cited: 1
Does Operative Time Modify Obesity-related Outcomes in THA?
Maveric Abella, John P. M. Angeles, Andrea K. Finlay, et al.
Clinical Orthopaedics and Related Research (2023) Vol. 481, Iss. 10, pp. 1917-1925
Closed Access | Times Cited: 3
Is Operative Time Associated With Obesity-related Outcomes in TKA?
Maveric Abella, John P. M. Angeles, Andrea K. Finlay, et al.
Clinical Orthopaedics and Related Research (2023) Vol. 482, Iss. 5, pp. 801-809
Closed Access | Times Cited: 2
Core Trainee Prize Winner: Weight loss drugs: their role and potential future in orthopaedic surgery
Thomas K. Doyle
Bone and Joint 360 (2024) Vol. 13, Iss. 3, pp. 12-15
Closed Access
Utilization of Glucagon-Like Peptide-1 Receptor Agonist at the Time of Total Hip Arthroplasty for Patients Who Have Morbid Obesity
Billy I. Kim, Tyler Khilnani, Scott M. LaValva, et al.
The Journal of Arthroplasty (2024)
Closed Access
An Update on the Management and Optimization of the Patient with Morbid Obesity Undergoing Hip or Knee Arthroplasty
Josef Jolissaint, Maria S. Kammire, Benjamin J. Averkamp, et al.
Orthopedic Clinics of North America (2023) Vol. 54, Iss. 3, pp. 251-257
Closed Access | Times Cited: 1
Assessment of Medical and Social Risk Factors Before Arthroplasty in Argentina: A Poll of Argentinian Hip and Knee Association (ACARO) Members
Francisco Nally, Lucas W. Campos, Fernando Comba, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 11, pp. 2238-2241
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top